| Name | Title | Contact Details |
|---|
AppleCare Medical Group is a Artesia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rockwell Medical Technologies, Inc. is a Wixom, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Privis Health is a leading provider of innovative data-driven population health programs and technology rich services that enable healthcare providers to deliver high quality efficient care to their patient population. Our scalable, cloud-based platform empowers healthcare providers to better manage risk, while achieving their operating and performance goals as they transition from fee-for-service to value based reimbursement. In addition, we assist with the design, implementation and expansion of population health programs, while sharing in the accountability for the success of these initiatives. The Privis team has deep experience with a programmatic approach to provide strategies on service models, organizational transformation, quality improvements and learning health system activities. Offerings include care management, care coordination, transitions of care, chronic care management, and complex CCM programs working in tandem with patient engagement and placement services. We provide a tool kit of evidence-based chronic disease and socio-behavioral assessments that drive the creation of a dynamic shared care plan. Our gaps-in-care offering captures important variances in care, such as preventive care, community resources, and guides interventions to assist the patient in achieving better outcomes and appropriate interventions
Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® Technology to transform the way people take medicine. Its first innovation, ZipDose Technology can be combined with a wide variety of active pharmaceutical ingredients to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address unmet treatment needs to eliminate patient suffering and caregiver burden.
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex`s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors.